Study Title
Study Details
Description:
This is a prospective, open-label, single-center clinical study targeting renal cell carcinoma. Sixty patients with a high clinical suspicion of renal cell carcinoma were included. Qualified subjects will undergo 68Ga-NOTA-RCCB6 PET/CT examination. The aim is to establish the optimal imaging protocol; evaluate the distribution characteristics and correlations of physiological and pathological positive uptake, and using pathological results as the gold standard, assess the diagnostic efficacy of 68Ga-NOTA-RCCB6 PET/CT in renal cell carcinoma.
Sponsor:
Xijing Hospital
Contacts:
Ying Guoguoying01192022@163.com
0086+15991459177
Government Study Link:
NCT06769893 - Click here to see study onClinicalTrials.gov
Drug Details